[Meningoencephalitis associated with cytomegalovirus, Herpes simplex and Varicella-zoster virus infections]. 2011

E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova

UI MeSH Term Description Entries
D008590 Meningoencephalitis An inflammatory process involving the brain (ENCEPHALITIS) and meninges (MENINGITIS), most often produced by pathogenic organisms which invade the central nervous system, and occasionally by toxins, autoimmune disorders, and other conditions. Cerebromeningitis,Encephalomeningitis,Cerebromeningitides,Encephalomeningitides,Meningoencephalitides
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D020803 Encephalitis, Herpes Simplex An acute (or rarely chronic) inflammatory process of the brain caused by SIMPLEXVIRUS infections which may be fatal. The majority of infections are caused by human herpesvirus 1 (HERPESVIRUS 1, HUMAN) and less often by human herpesvirus 2 (HERPESVIRUS 2, HUMAN). Clinical manifestations include FEVER; HEADACHE; SEIZURES; HALLUCINATIONS; behavioral alterations; APHASIA; hemiparesis; and COMA. Pathologically, the condition is marked by a hemorrhagic necrosis involving the medial and inferior TEMPORAL LOBE and orbital regions of the FRONTAL LOBE. (From Adams et al., Principles of Neurology, 6th ed, pp751-4) Herpes Simplex Encephalitis,Herpetic Acute Necrotizing Encephalitis,Meningoencephalitis, Herpes Simplex Virus,Acute Necrotizing Encephalitis, Herpetic,Herpes Encephalitis,Herpes Simplex Meningoencephalitis,Herpetic Encephalitis,Herpetic Meningoencephalitis,Encephalitides, Herpes Simplex,Encephalitides, Herpetic,Encephalitis, Herpes,Encephalitis, Herpetic,Herpes Simplex Encephalitides,Herpes Simplex Meningoencephalitides,Herpetic Encephalitides,Herpetic Meningoencephalitides,Meningoencephalitides, Herpes Simplex,Meningoencephalitides, Herpetic,Meningoencephalitis, Herpes Simplex,Meningoencephalitis, Herpetic
D020804 Encephalitis, Varicella Zoster Inflammation of brain tissue caused by infection with the varicella-zoster virus (HERPESVIRUS 3, HUMAN). This condition is associated with immunocompromised states, including the ACQUIRED IMMUNODEFICIENCY SYNDROME. Pathologically, the virus tends to induce a vasculopathy and infect oligodendrocytes and ependymal cells, leading to CEREBRAL INFARCTION, multifocal regions of demyelination, and periventricular necrosis. Manifestations of varicella encephalitis usually occur 5-7 days after onset of HERPES ZOSTER and include HEADACHE; VOMITING; lethargy; focal neurologic deficits; FEVER; and COMA. (From Joynt, Clinical Neurology, 1996, Ch 26, pp29-32; Hum Pathol 1996 Sep;27(9):927-38) Encephalitis, Human Herpesvirus 3,Herpes Zoster Encephalitis,Meningoencephalitis, Herpes Zoster,Varicella Encephalitis,Encephalitis, Herpes Zoster,Encephalitis, VZ Virus,Encephalitis, Varicella,Herpes Zoster Meningoencephalitis,Varicella Zoster Encephalitis,Varicella Encephalitides,Virus Encephalitis, VZ,Zoster Encephalitis, Herpes,Zoster Encephalitis, Varicella

Related Publications

E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
August 2004, Pediatric clinics of North America,
E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
October 2022, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
October 2003, Therapeutische Umschau. Revue therapeutique,
E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
January 1992, Heart & lung : the journal of critical care,
E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
April 1997, Nihon rinsho. Japanese journal of clinical medicine,
E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
September 2002, The Medical journal of Australia,
E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
June 2012, Journal of the American Academy of Dermatology,
E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
March 1997, The Western journal of medicine,
E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
November 1987, Journal of clinical microbiology,
E P Dekonenko, and Iu P Rudometov, and S A Rusanova, and M V Sokolov, and I Kh Belialetdinova
June 1988, Infectious disease clinics of North America,
Copied contents to your clipboard!